We recently compiled a list of the 11 Best Undervalued Stocks to Invest in Now. In this article, we are going to take a look ...
Narasimhan said that an informal target would be a spend of around 5% of Novartis’ market cap on M&A each year, which would equate to around $10 billion, as the process of “redesigning” the ...
Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG (NOVN – Research Report) on March 13 and set a price target of ...